MedPath

Effect of Levonorgestrel Intrauterine System on Hemoglobin Level

Not Applicable
Not yet recruiting
Conditions
Hemoglobin; Deficiency
Registration Number
NCT06935968
Lead Sponsor
Assiut University
Brief Summary

To study the effect of LNG-IUS on improving iron status in reproductive-aged women presenting for contraception.

Detailed Description

Women come to family planning clinic to insert levonorgestrel intrautrine system and take a blood sample from her to analyse hemoglobin level

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Female
Target Recruitment
100
Inclusion Criteria
  1. The study will include married women attending the outpatient clinics of the forementioned health facilities for contraception counseling
  2. Age between 18 and 45 years
  3. Women who choose LNG_IUS for contraception
  4. Any parity including nulliparous
Exclusion Criteria
  • 1.Women with any inherited hemoglobinopathy (thalassemia, sickle cell anemia) or acquired hemolytic anemia 2.Women with sever iron deficiency anemia requiring immediate treatment 3.Women with any contraindication to Mirena insertion (pelvic inflammatory disease, cervical or vaginal infection, cervical cancer) 4. Any uterine abnormality making LNG_IUS insertion difficult (septate uterus or fibroid distorting the cavity) 5. Women within 6 months of delivery

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Change of blood haemoglobin level from time of insertion to 6 months after insertion6 months

To know the effect of LNG-IUDs on hemoglobin level after insertion

Secondary Outcome Measures
NameTimeMethod
Change of serum ferritin level from time of insertion to 6 months after insertionPrevalence of iron deficiency and iron deficiency anemia in women requiring contraception in our community6 months

To know the effect of LNG-IUDs in serum ferritin

© Copyright 2025. All Rights Reserved by MedPath